Clinical Trial Update: Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)

View source ↗

Summary

A completed observational surveillance study of Gardasil (V501-031) to detect potential safety signals after vaccination, with results posted in January 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Papillomavirus Infection | Status: COMPLETED | Results posted: 2012-01-09